Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.950
-0.050 (-1.25%)
At close: Feb 12, 2026
Market Cap108.55M -8.1%
Revenue (ttm)33.00M +22.6%
Net Income9.09M +258.7%
EPS0.23 +258.7%
Shares Out38.76M
PE Ratio11.92
Forward PEn/a
Dividend0.04 (1.27%)
Ex-Dividend DateApr 23, 2025
Volume1,000
Average Volume19,468
Open3.950
Previous Close4.000
Day's Range3.950 - 3.950
52-Week Range3.550 - 4.450
Beta-0.09
RSI44.78
Earnings DateFeb 17, 2026

About PEX:BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company provides its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, central nervous system, endocrines, genito-urinary system, diabetes, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and ... [Read more]

Industry Pharmaceutical Preparations
Founded 1973
Employees 300
Stock Exchange Palestine Stock Exchange
Ticker Symbol BPC
Full Company Profile

Financial Performance

In 2024, PEX:BPC's revenue was $40.65 million, a decrease of -5.74% compared to the previous year's $43.13 million. Earnings were $5.18 million, a decrease of -15.26%.

Financial numbers in USD Financial Statements